CIK 0001637715 · <br>Emerging growth company
OnKure Therapeutics, Inc.
Sign in to watch- Ticker
- OKUR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 472309515
- Phone
- (720) 307-2892
- Business address
- 6707 WINCHESTER CIRCLE, SUITE 400, BOULDER, CO, 80301
- Former names
- Reneo Pharmaceuticals, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,157
- in 2 filings
Net −$1,157. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 35 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-21 | Leverone Jason A. Chief Financial Officer | Sale | −302 | $2.97 | $898 | 18,500 |
| 2026-09-21 | Saccomano Nicholas A President and CEO | Sale | −87 | $2.97 | $259 | 11,160 |
| 2026-06-22 | Leverone Jason A. Chief Financial Officer | Sale | −303 | $4.40 | $1K | 18,802 |
| 2026-06-22 | Saccomano Nicholas A President and CEO | Sale | −86 | $4.40 | $378 | 11,247 |
| 2026-03-23 | Leverone Jason A. Chief Financial Officer | Sale | −301 | $4.16 | $1K | 16,000 |
| 2026-03-23 | Saccomano Nicholas A President and CEO | Sale | −86 | $4.16 | $357 | 7,333 |
| 2025-12-22 | Leverone Jason A. Chief Financial Officer | Sale | −302 | $2.97 | $896 | 16,301 |
| 2025-12-22 | Saccomano Nicholas A President and CEO | Sale | −87 | $2.97 | $258 | 7,419 |
| 2025-09-22 | Leverone Jason A. Chief Financial Officer | Sale | −303 | $2.62 | $795 | 12,603 |
| 2025-09-22 | Saccomano Nicholas A President and CEO | Sale | −88 | $2.62 | $231 | 3,506 |
| 2025-06-23 | Saccomano Nicholas A President and CEO | Sale | −88 | $2.38 | $210 | 3,594 |
| 2025-06-23 | Leverone Jason A. Chief Financial Officer | Sale | −303 | $2.38 | $722 | 12,906 |
| 2025-05-15 | Cormorant Asset Management, LP Former 10% Owner | Sale | −1,813,439 | $1.85 | $3.4M | 0 |
| 2025-05-12 | Cormorant Asset Management, LP 10% owner | Sale | −24,300 | $1.99 | $48K | 1,813,439 |
| 2025-04-07 | Saccomano Nicholas A President and CEO | Sale | −516 | $2.67 | $1K | 3,682 |
| 2025-04-07 | Leverone Jason A. Chief Financial Officer | Sale | −1,844 | $2.67 | $5K | 13,209 |
| 2025-04-04 | Saccomano Nicholas A President and CEO | Sale | −358 | $3.33 | $1K | 4,198 |
| 2025-04-04 | Leverone Jason A. Chief Financial Officer | Sale | −1,278 | $3.33 | $4K | 15,053 |
| 2023-08-28 | Hall Ashley Chief Development Officer | Sale | −15,625 | $6.28 | $98K | 39,600 |
| 2023-06-23 | Novo Holdings A/S 10% owner | Sale | −100,000 | $7.10 | $710K | 3,330,337 |
Page 1 of 1 · 20 trades